Human Cytochrome c Platinum ELISA

Also known as: CYC, somatic Cytochrome C, HCS

RUO: For Research Use Only. Not for use in diagnostic procedures.

SKU# BMS263*

Cat. No. Size
BMS263 96 tests
BMS263TEN 10 x 96 tests
Please inquire about custom configurations or bulk packaging.

To enable ordering, please select your country. Cookies will need to be enabled to continue on our website. View our Privacy Policy.

Data for Human Cytochrome c Platinum ELISA.

Click on image to view more information.

  • Data for Human Cytochrome c Platinum ELISA.
Description

Description: The human Cytochrome c ELISA is an enzyme-linked immunosorbent assay for the quantitative detection of human Cytochrome c. The human Cytochrome c ELISA is for research use only. Not for diagnostic or therapeutic procedures.

Cytochrome c was identified as a component required for the crucial steps in apoptosis, caspase-3 activation and DNA fragmentation. Cytochrome c was shown to redistribute from mitochondria to cytosol during apoptosis in intact cells.

Mitochrondrial cytochrome c is a water-soluble protein of 15 kDa with a net positive charge, residing loosely attached in the mitochrondrial intermembrane space. Cytochrome c functions in the respiratory chain by interaction with redox partners. The release of cytochrome c into the cytosol leads to an activation of an apoptotic program via activation of a caspase dependent pathway. Cytochrome c achieves this goal by interaction with other cytosolic factors forming a complex (apoptosome) composed of cytochrome c, Apaf-1, dATP and Apaf-3/caspase 9. Bcl-2 on the other hand was shown to be able to prevent apoptosis by blocking the release of cytochrome c from mitochondria. Measurement of cytochrome c release from the mitochondria is a tool to detect the first early steps for initiating apoptosis in cells. Moreover, elevated cytochrome c levels were observed in serum from patients with hematological malignancies. In the course of cancer chemotherapy, the serum-cytochrome c level grew rapidly and it decreased gradually as the patient was cleared from malignant cells. Thus, serum-cytochrome c monitoring might serve as a clinical marker indicating the onset of apoptosis and cell turn-over in vivo.

Details
Reactivity Human
Sample Volume 100 uL (prediluted)
Suitable Sample Types cell lysate
Sensitivity 0.05 ng/mL
Standard Curve Range 0.08 - 5.0 ng/mL
Components Aluminium pouch(es) with a Microwell Plate coated with monoclonal antibody to human Cytochrome c
Biotin-Conjugate anti-human Cytochrome c monoclonal antibody
Streptavidin-HRP
Human Cytochrome c Standard lyophilized, 10 ng/ml upon reconstitution
Assay Buffer Concentrate 20x (PBS with 1% Tween 20 and 10% BSA)
Wash Buffer Concentrate 20x (PBS with 1% Tween 20)
Lysis Buffer 10x
Substrate Solution (tetramethyl-benzidine)
Stop Solution (1M Phosphoric acid)
Green-Dye
Red-Dye
Adhesive Films
Reported Applications ELISA
Documentation
TDS Link Download TDS
Related Products
Cat. No. Name Excite Emit Application Reg.
88-6671 Apo-BrdU Apoptosis Detection FC, ICC RUO
88-7004 CaspGLOW™ Fluorescein Active Caspase-3 Staining Kit FC, ICC RUO
BMS2004* Human TRAIL Platinum ELISA ELISA RUO
BMS244/3* Human Bcl-2 Platinum ELISA ELISA RUO
BMS500FI* Annexin V-FITC Apoptosis Detection Kit 488 nm FC RUO
References

Citations: Stolz,Claudia; Hess,Georg; Hahnel,Patricia S.; Grabellus,Florian; Hoffarth,Sandra; Schmid,Kurt W.; Schuler,Martin. Targeting Bcl-2 family proteins modulates the sensitivity of B-cell lymphoma to rituximab-induced apoptosis. Blood 2008;112:3312-3321. (Link)

Ben-Ari,Z.; Schmilovotz-Weiss,H.; Belinki,A.; Pappo,O.; Sulkes,J.; Neuman,M.G.; Kaganovsky,E.; Kfir,B.; Tur-Kaspa,R.; Klein,T.. Circulating soluble cytochrome c in liver disease as a marker of apoptosis464. Journal of Internal Medicine 2003;254:168-175. (Link)

Yu,Jian Qing; Liu,Hui Bin; Tian,Dai Zhi; Liu,Yan Wen; Lei,Jia Chuan; Zou,Guo Lin. Changes in mitochondrial membrane potential and reactive oxygen species during wogonin-induced cell death in human hepatoma cells. Hepatology Research 2007;37:68-76. (Link)

Satchell,Margaret; Lai,Yichen; Kochanek,Patrick; Wisniewski,Stephen; Fink,Ericka; Siedberg,Neal; Berger,Rachel; Dekosky,Steven; David,Adelson; Clark,Robert. Cytochrome c, a biomarker of apoptosis, is increased in cerebrospinal fluid from infants with inflicted brain injury from child abuse. J Cereb Blood Flow Metab 2005;25:919-927. (Link)

Kerr,L.; Birse-Archbold,L.A.; Short,D.; McGregor,A.; Heron,I.; MacDonald,D.; Thompson,J.; Carlson,G.; Kelly,J.; McCulloch,J.; Sharkey,J.. Nucleophosmin is a novel Bax chaperone that regulates apoptotic cell death. Oncogene 2006;26:2554-2562. (Link)

Rouet-Benzineb,Patricia; Rouyer-Fessard,Christiane; Jarry,Anne; Avondo,Virgile; Pouzet,Cecile; Yanagisawa,Masashi; Laboisse,Christian; Laburthe,Marc; Voisin,Thierry. Orexins Acting at Native OX1 Receptor in Colon Cancer and Neuroblastoma Cells or at Recombinant OX1 Receptor Suppress Cell Growth by Inducing Apoptosis. Journal of Biological Chemistry 2004;279:45875-45886. (Link)

References: Tschopp,J.; Thome,M.; Hofmann,K.; Meinl,E.. The fight of viruses against apoptosis. Curr.Opin.Genet.Dev. 1998;8:82-87. (Link)

Green,D.R.; Reed,J.C.. Mitochondria and apoptosis. Science 1998;281:1309-1312. (Link)

Bossy-Wetzel,E.; Newmeyer,D.D.; Green,D.R.. Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization. EMBO J. 1998;17:37-49. (Link)

Jacobson,M.D.; Weil,M.; Raff,M.C.. Programmed cell death in animal development. Cell 1997;88:347-354. (Link)

Yang,J.; Liu,X.; Bhalla,K.; Kim,C.N.; Ibrado,A.M.; Cai,J.; Peng,T.I.; Jones,D.P.; Wang,X.. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 1997;275:1129-1132. (Link)

Slee,E.A.; Harte,M.T.; Kluck,R.M.; Wolf,B.B.; Casiano,C.A.; Newmeyer,D.D.; Wang,H.G.; Reed,J.C.; Nicholson,D.W.; Alnemri,E.S.; Green,D.R.; Martin,S.J.. Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J.Cell Biol. 1999;144:281-292. (Link)

Renz,A.; Berdel,W.E.; Kreuter,M.; Belka,C.; Schulze-Osthoff,K.; Los,M.. Rapid extracellular release of cytochrome c is specific for apoptosis and marks cell death in vivo 105. Blood 2001;98:1542-1548. (Link)

Hakem,R.; Hakem,A.; Duncan,G.S.; Henderson,J.T.; Woo,M.; Soengas,M.S.; Elia,A.; de la Pompa,J.L.; Kagi,D.; Khoo,W.; Potter,J.; Yoshida,R.; Kaufman,S.A.; Lowe,S.W.; Penninger,J.M.; Mak,T.W.. Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell 1998;94:339-352. (Link)

Kluck,R.M.; Bossy-Wetzel,E.; Green,D.R.; Newmeyer,D.D.. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 1997;275:1132-1136. (Link)

Reed,J.C.; Jurgensmeier,J.M.; Matsuyama,S.. Bcl-2 family proteins and mitochondria. Biochim.Biophys.Acta 1998;1366:127-137. (Link)

Kluck,R.M.; Martin,S.J.; Hoffman,B.M.; Zhou,J.S.; Green,D.R.; Newmeyer,D.D.. Cytochrome c activation of CPP32-like proteolysis plays a critical role in a Xenopus cell-free apoptosis system. EMBO J. 1997;16:4639-4649. (Link)